Novartis International AG /
Novartis drug Revolade® recommended by CHMP for EU approval to treat patients
with severe aplastic anemia, a serious blood disorder
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement. ...
↧